Drugs / Interferon-alpha
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01765088 | Sep 2012 → Dec 2017 | anaplastic astrocytoma, anaplastic oligoastrocytoma, glioblastoma | Sun Yat-sen University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Interferon-alpha | “addition of Interferon-alpha(α-IFN),which were determined sensitized the activity of Temozolomide(TMZ) in vivo and vitro” NCT01765088 ↗ |
| Known as | α-IFN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01765088 ↗ |